Compound information
- Natural Products
- ZC2298858
- Molecular Formula
- C21H21N5OS
- Molecular Weight
- 391.146681292 g/mol
- Structure
-
- IUPAC Name
- N-(9H-fluoren-2-yl)-4-(3-methyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide
- InChI
- InChI=1S/C21H21N5OS/c1-14-22-21(28-24-14)26-10-8-25(9-11-26)20(27)23-17-6-7-19-16(13-17)12-15-4-2-3-5-18(15)19/h2-7,13H,8-12H2,1H3,(H,23,27)
- InChI Key
- JRPUFADZBJJWJA-UHFFFAOYSA-N
- SMILES
- Cc1nsc(N2CCN(C(=O)Nc3ccc4c(c3)Cc3ccccc3-4)CC2)n1
- Source
- ZINC000079019485
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 28 | Ring Count | 5 |
Heteroatom Count | 7 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 61.36 Å2 | LogP | 4.134 |
LogS | -5.351 | LogD | 3.705 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.24 | Pgp substrate | 0.99 |
HIA | 0.965 | F20 % | 0.988 |
F30 % | 0.977 | Caco-2 | -4.752 |
MDCK | -5.057 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.025 | PPB | 97.831 |
VD | 1.669 | Fu | 1.721 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.986 | CYP1A2 substrate | 0.797 |
CYP2A6 substrate | 0.346 | CYP2B6 substrate | 0.713 |
CYP2C19 inhibitor | 0.879 | CYP2C19 substrate | 0.84 |
CYP2C8 substrate | 0.816 | CYP2C9 inhibitor | 0.933 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.037 |
CYP2D6 substrate | 0.978 | CYP2E1 substrate | 0.222 |
CYP3A4 inhibitor | 0.157 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.149 | CL | 2.95 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.767 | Hepatotoxicity | 0.968 |
Mutagenicity | 0.038 | Rat Oral Acute Toxicity | 0.411 |
FDAMDD | 0.769 | Skin Sensitization | 0.392 |
Carcinogenicity | 0.985 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.977 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.635 | IGC50 | 3.79 |
LC50FM | -5.255 | LC50DM | -8.393 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.724 | NR-AR-LBD | 0.34 |
NR-AhR | 0.81 | NR-Aromatase | 0.042 |
NR-ER | 0.732 | NR-ER-LBD | 0.407 |
NR-PPAR-gamma | 0.817 | SR-ARE | 0.904 |
SR-ATAD5 | 0.813 | SR-HSE | 0.085 |
SR-MMP | 0.2 | SR-p53 | 0.658 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.